[Cell-mediated immunity and delayed hypersensitivity study in splenectomy patients: a comparative evaluation between

S Miniello1, E Jirillo, G Urgesi

  • 1Istituto di Chirurgia Generale II, Università degli Studi, Bari.

Chirurgia Italiana
|January 14, 2000
PubMed

Insights

Skin tests (ST) effectively identify immunocompromised patients post-splenectomy, outperforming serum interferon-gamma (IFN-γ) tests. This simple method aids daily monitoring of immune status in asplenic individuals.

Area of Science:

  • Immunology
  • Clinical Medicine
  • Surgical Outcomes

Background:

  • Splenectomy can lead to immunocompromise, increasing infection risk.
  • Assessing immune status in asplenic individuals is crucial for patient management.
  • Current methods for monitoring immune function can be complex or costly.

Purpose of the Study:

  • To evaluate the feasibility, ease of use, and cost-effectiveness of skin tests (ST) for daily monitoring of immunocompromise in splenectomized patients.
  • To compare the efficacy of ST with serum interferon-gamma (IFN-γ) dosage in assessing cell-mediated immunity and delayed hypersensitivity.

Main Methods:

  • Skin tests (ST) were administered to splenectomized subjects.
  • Serum samples were analyzed for interferon-gamma (IFN-γ) levels.
  • Results from ST and IFN-γ assays were compared to assess immune compromise.

Main Results:

  • Skin tests demonstrated 100% effectiveness in identifying immunocompromised splenectomized patients.
  • Serum IFN-γ dosage indicated immune compromise in only 60% of the same patient group.
  • The study confirmed the role of cytokines like IL-2 in immune status.

Conclusions:

  • Skin tests offer a feasible, inexpensive, and highly effective method for daily monitoring of immunocompromise in splenectomized individuals.
  • ST provide a more sensitive indicator of immune compromise compared to serum IFN-γ levels in this population.
  • This approach can aid in the early detection and management of immune dysfunction post-splenectomy.